Zambia has signed a Memorandum of Understanding (MOU) with China to establish its first cholera vaccine manufacturing facility, officials announced Monday.
The initiative aims to bolster Zambia’s efforts in combating cholera, a disease that has significantly impacted public health and productivity. The initial phase of the plant, which will cost $37 million, is a partnership between Zambia’s Industrial Development Corporation (IDC) and China’s Jijia International Medical Technology Corporation. The facility is projected to produce approximately three million doses annually.
Zambian President Hakainde Hichilema highlighted the project’s significance during the signing ceremony in Lusaka, emphasizing its role in eradicating cholera. He noted that Zambia could emerge as a manufacturing hub for Africa amid the continent’s rapid population growth.
“This partnership sends a message that Zambia, Africa, and the world can collaborate effectively. We aim to make Zambia a center for manufacturing to serve larger markets,” Hichilema said.
The president also urged that the project avoid bureaucratic delays due to its critical, life-saving nature. Under the agreement, China will donate three million cholera vaccine doses to Zambia prior to the start of local production.
Zambia experienced a severe cholera outbreak earlier this year, resulting in over 400 deaths and more than 10,000 infections. Cholera remains a persistent threat in the country, especially during the rainy season, despite being a curable disease.
